Daily Dose - Jan 6th, 2025
Daily Dose |
View online
January 6, 2025
How dealmaking may jumpstart CGT development again
Contrasting the fortunes of other hot drug classes, it is possible that CGTs may have reached their apex. So, where do they go next?
Read More
China’s WuXi Biologics sells Irish vaccine facility to Merck for $500M
The sale of the Chinese CDMO’s manufacturing site in Ireland comes weeks after WuXi AppTec announced it was selling WuXi Advanced Therapies to a U.S. firm.
Read More
Novo Holdings invests in Orbis Medicines to advance macrocycle manufacturing
Orbis’ nGen platform focuses on optimizing macrocycles for oral bioavailability, a long-standing hurdle in drug manufacturing.
Read More